Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

LYEL

Lyell Immunopharma Inc

Jun 05 • 04:00PM ET

11.97

-1.08 -8.28 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: EDIT BEAM NTLA BMRN CRSP INCY KRYS AXSM NBIX VSTM

| Held by: VTI VXF SCHA IBB VHT AVSC DFAS DFMC SCHB PRFZ

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-12.74	Insider Own	66.70%	Shs Outstand	23.33M	Perf Week	-30.93%
Market Cap	279.31M	Forward P/E	-	EPS next Y	-7.99	Insider Trans	6.59%	Shs Float	7.77M	Perf Month	-42.59%
Enterprise Value	74.14M	PEG	-	EPS next Q	-2.03	Inst Own	18.91%	Short Float	17.25%	Perf Quarter	-46.71%
Income	-246.41M	P/S	9310.33	EPS this Y	52.16%	Inst Trans	0.57%	Short Ratio	14.46	Perf Half Y	-46.35%
Sales	0.03M	P/B	1.02	EPS next Y	-4.00%	ROA	-63.15%	Short Interest	1.34M	Perf YTD	-61.11%
Book/sh	11.73	P/C	1.10	EPS next 5Y	23.93%	ROE	-80.76%	52W High	45.00 -73.40%	Perf Year	4.45%
Cash/sh	10.89	P/FCF	-	EPS past 3/5Y	-2.70% 0.99%	ROIC	-78.69%	52W Low	8.46 41.49%	Perf 3Y	-82.50%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-92.48% -65.85%	Gross Margin	-33545.16%	Volatility	13.59% 8.74%	Perf 5Y	-
Dividend TTM	-	EV/Sales	2471.33	EPS Y/Y TTM	49.06%	Oper. Margin	-620790.32%	ATR (14)	1.47	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.23	Sales Y/Y TTM	-52.31%	Profit Margin	-794858.06%	RSI (14)	23.85	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	7.23	EPS Q/Q	68.79%	SMA20	-28.64%	Beta	-0.01	Target Price	37.17
Payout	-	Debt/Eq	0.18	Sales Q/Q	-71.43%	SMA50	-39.92%	Rel Volume	1.04	Prev Close	13.05
Employees	161	LT Debt/Eq	0.14	Earnings	May 06 AMC	SMA200	-42.11%	Avg Volume	92.70K	Price	11.97
IPO	Jun 17, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.14% -33.33%	Trades		Volume	96,686	Change	-8.28%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)